Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
4,66 HKD | -2,71% |
|
-12,57% | -39,01% |
05/06 | 3D Medicines nominerà nuovi revisori dei conti | MT |
29/03 | La perdita di 3D Medicines nel 2023 quasi si dimezza, mentre le entrate aumentano del 12%. | MT |
Attività
Numero di dipendenti: 198
Vendite per attività
HKD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Biopharmaceutical Research and Development
100,0
%
| 660 | 100,0 % | 702 | 100,0 % | +6,34% |
Vendite per regione
HKD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
China
100,0
%
| 660 | 100,0 % | 702 | 100,0 % | +6,34% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Zhao Long Gong
CEO | Chief Executive Officer | 60 | 01/01/14 |
Jing Zhang
DFI | Director of Finance/CFO | 50 | 28/08/20 |
Zhi Qiang Xue
CTO | Chief Tech/Sci/R&D Officer | - | - |
Ming Zhu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Shen Xiao
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/21 |
Fang Xia
IRO | Public Communications Contact | 43 | 01/09/20 |
Yue He
PRN | Corporate Officer/Principal | 46 | 01/08/19 |
Yihui Lin
PRN | Corporate Officer/Principal | 44 | 30/01/18 |
Ching Yi Li
SEC | Corporate Secretary | - | 25/06/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Tat Pang Lin
BRD | Director/Board Member | 67 | 01/12/22 |
Xin Guang Liu
BRD | Director/Board Member | 63 | 25/06/21 |
Zhao Long Gong
CEO | Chief Executive Officer | 60 | 01/01/14 |
Jin Li
BRD | Director/Board Member | 59 | 25/06/21 |
Pai Zhu
BRD | Director/Board Member | 31 | 23/06/21 |
Feng Zhou
BRD | Director/Board Member | 42 | 09/10/19 |
Yawen Chen
BRD | Director/Board Member | 32 | 12/07/22 |
Coordinate società
![Indirizzo 3D Medicines Inc.(1244)](https://cdn.zonebourse.com/static/address/147680264.png)
Settore
Variaz. 1 gen. | Capi. | |
---|---|---|
-39,01% | 146 Mln | |
+16,61% | 122 Mrd | |
+17,75% | 112 Mrd | |
+17,23% | 25,91 Mrd | |
-24,11% | 19,33 Mrd | |
-18,56% | 16,17 Mrd | |
-18,47% | 15,6 Mrd | |
-47,75% | 14,65 Mrd | |
+57,35% | 14,34 Mrd | |
+5,62% | 14 Mrd |
- Borsa valori
- Azioni
- Azione 1244
- Società 3D Medicines Inc.